PerkinElmer Acquires Project Farma from Precision for Medicine

Precision Medicine Group Acquires Project Farma

January 14, 2021

Healthcare Services

Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.

Precision for Medicine Acquires Baseline Controls

June 27, 2023

Healthcare Services

Precision for Medicine has acquired Baseline Controls, a Raleigh-based project controls and project management firm, and will integrate its capabilities into Project Farma to broaden end-to-end biomanufacturing solutions for life science companies. The acquisition expands Precision for Medicine’s technical operations and project planning expertise—targeting faster, more cost-efficient manufacturing for small molecule, biologics and next-generation therapies including cell and gene therapy.

ProPharma Group Acquires Pharmica Consulting

October 6, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.

Fagron Acquires Purifarma (Brazil)

January 6, 2026

Pharmaceuticals

Fagron has completed the acquisition of Purifarma in Brazil following CADE approval, strengthening Fagron's scale in Essentials and advancing its buy-and-build strategy. Purifarma is a large-scale distributor/importer of pharmaceutical, food and cosmetic inputs; the transaction carries an enterprise value of approximately R$250 million and is expected to deliver product-mix improvements, access to industrial customers and purchasing synergies across Latin America.

Fagron Acquires Purifarma in Brazil

January 6, 2026

Pharmaceuticals

Fagron has completed the acquisition of Purifarma, a large-scale pharmaceutical essentials business in Brazil, for an enterprise value of approximately R$250 million. The deal strengthens Fagron's scale and procurement position in Latin America and supports the Group's buy-and-build strategy to expand its pharmaceutical compounding and essentials platform.

FAMAR Acquires Homburg Sterile Manufacturing Site from MiP Pharma (MidEuropa-backed)

May 13, 2025

Pharmaceuticals

MidEuropa-backed portfolio company FAMAR signed an agreement to acquire a sterile manufacturing production site in Homburg (Saar), Germany from MiP Pharma. The addition expands FAMAR’s aseptic and lyophilised fill & finish capabilities and increases its European sterile manufacturing footprint to seven facilities, providing immediate capacity to serve international clients.